A carregar...
Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes
AIMS: To explore the effects of dual therapy with dapagliflozin and exenatide on body weight, body composition, glycaemic variables and systolic blood pressure (SBP) in obese adults without diabetes. MATERIALS AND METHODS: In this single‐centre, double‐blind trial, we randomized 50 obese adults with...
Na minha lista:
| Publicado no: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215525/ https://ncbi.nlm.nih.gov/pubmed/27550386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12779 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|